Anti‐hyperglycemic Potential of Algerian Trigonella foenum‐graecum L. Seed Extract in Type 1 Diabetic Rats: Combined In Vivo Studies and In Silico Docking Analysis of Bioactive Phenolic Compounds
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202402836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Lilya Chelbi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Neuroendocrinology Biology Department, Sciences Faculty, Badji-Mokhtar Annaba University, Annaba, Algeria. Hauptthemen laut MEDLINE: Trigonella, Hypoglycemic Agents, Diabetes Mellitus, Experimental, Plant Extracts. Die Arbeit nennt 68 Literaturangaben.
Abstract (Originalsprache)
Type 1 diabetes (T1D) poses a significant global health challenge, with current treatments often proving inadequate. This study provides a comprehensive evaluation of the anti‐hyperglycemic effects of methanolic extract from Algerian Trigonella foenum‐graecum L. seeds (MEF) in Type 1 diabetic rats, combining both in vivo and in silico studies: molecular docking and ADMET. Polyphenol compounds (PCs) identified. Twenty‐four male rats divided into four groups: control, normal treated with MEF, diabetic, and diabetic treated with MEF. T1D was induced via a single intraperitoneal injection: i.p. 50 mg/kg streptozotocin injection. MEF was administered orally at a dose of 400 mg/kg body weight for 28 days, with measurements of body weight and fasting blood glucose. Histopathological examinations of pancreatic tissues were conducted posttreatment. HPLC identified 15 PCs. We found that six main PCs had strong binding affinities for the IR (−9.463 to −7.893 kcal/mol). The ADMET modeling indicated favorable drug‐likeness, oral bioavailability, and no toxicity risk. Significantly, diabetic rats treated with MEF exhibited a marked reduction in fasting blood glucose levels (494.67–144.17 mg/dL; p < 0.001), along with an increase in body weight and improvements in the pancreatic islets of Langerhans. These findings suggest that MEF possesses substantial anti‐hyperglycemic potential and may play a role in managing T1D complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Applied Neuroendocrinology Biology Department, Sciences Faculty, Badji-Mokhtar Annaba University, Annaba, Algeria.
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modelling Group, Sciences Faculty, Chemistry Department, Badji-Mokhtar Annaba University, Annaba, Algeria.
- Laboratory of Animal Ecophysiology, Biology Department, Sciences Faculty, Badji-Mokhtar Annaba University, Annaba, Algeria.
ORCID-Profile: Lilya Chelbi, Habiba Ferhati, Narimene Chelbi
Zitieren
APA
Chelbi, L., Ferhati, H., Rizi, A., Chelbi, N., & Bairi, A. (2025). Anti‐hyperglycemic Potential of Algerian Trigonella foenum‐graecum L. Seed Extract in Type 1 Diabetic Rats: Combined In Vivo Studies and In Silico Docking Analysis of Bioactive Phenolic Compounds. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402836
Vancouver
Chelbi L, Ferhati H, Rizi A, Chelbi N, Bairi A. Anti‐hyperglycemic Potential of Algerian Trigonella foenum‐graecum L. Seed Extract in Type 1 Diabetic Rats: Combined In Vivo Studies and In Silico Docking Analysis of Bioactive Phenolic Compounds. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402836
BibTeX
@article{Chelbi2025,
author = {Chelbi, Lilya and Ferhati, Habiba and Rizi, Aicha and Chelbi, Narimene and Bairi, Abdeladjid},
title = {Anti‐hyperglycemic Potential of Algerian Trigonella foenum‐graecum L. Seed Extract in Type 1 Diabetic Rats: Combined In Vivo Studies and In Silico Docking Analysis of Bioactive Phenolic Compounds},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202402836}
}
EUVIMED